How HIV cracks the lock to the cell nucleus
Human immunodeficiency virus type 1 (HIV-1) targets important cells of our immune system, making infected individuals more ...
New Atlas2d
"Kick and kill": HIV cure could be hiding in FDA-approved drug
HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found ...
IFLScience on MSN1d
EBC-46 Shows Tremendous Potential To Help Eradicate HIV
A new chemical compound has been making a big impression in the fight against cancer in recent years. Now it seems EBC-46, ...
Acsh.org4d
AIDS Denialism Was Rejected Long Ago. It May Be Back
Pseudoscience has recently been reemerging in the US. While much of it concerns vaccines, an "oldie" is again making the ...
A cure for HIV: 'One of the hardest goals in science'
Curing HIV will be harder than curing cancer. But new research is promising.HIV is "like a time bomb," said James Riley, a microbiologist at University of Pennsylvania, US. Scott Kitchen, an expert in ...
Medscape6d
Role of CXCR4 in HIV Infection and its Potential as a Therapeutic Target
Determinants of HIV cell tropism & chemokine receptor usage The V3 loop of HIV-1 gp120 is a primary determinant of cell tropism and chemokine receptor usage, whereas the V1/V2 region is involved ...
Viral protein Nef enables a step toward off-the-shelf CAR T cell therapy for cancer
CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a ...
technologynetworks6d
Blushwood Compound Offers Hope for HIV Cure Through "Kick and Kill" Strategy
Stanford researchers highlight the potential of EBC-46, a compound derived from Australia’s blushwood tree, in eradicating HIV. Acting as a potent latency-reversing agent, EBC-46 activates dormant ...
Science Daily3d
HIV and AIDS News
2024 — An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a new study. By targeting infected cells in the brain ...